New stock news | Stone Pharmaceutical Innovation (300765.SZ) filed for listing on the Hong Kong Stock Exchange.

According to the disclosure on December 10 by the Hong Kong Stock Exchange, Chisheng Innovation Pharmaceutical Co., Ltd. (referred to as Chisheng Innovation, 300765.SZ) has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with CITIC SEC as its exclusive sponsor. According to the prospectus, the company focuses on research and development, production, and commercialization of biopharmaceuticals, functional raw materials, and health food. According to Frost & Sullivan data, from 2020 to 2024, the company has consistently maintained its position as the world's largest chemical synthesis caffeine producer in terms of revenue and shipment volume. Since its establishment in 2006, the company has always focused on the research and production of high-quality caffeine. The company mainly produces caffeine as a food additive for functional beverages. According to Frost & Sullivan data, from 2020 to 2024, the company has consistently maintained its position as the world's largest chemical synthesis caffeine producer in terms of revenue and shipment volume. As of the last feasible date (December 1, 2025), the company's products have been sold to 65 countries and regions globally, with its main markets being North America and Europe. With stable product quality, cost advantages from scale production, and a sound supply chain system, the company has established solid cooperation relationships with leading customers in the international beverage industry. The company is a global caffeine supplier to industry giants such as The Coca-Cola Company (since 2006), PepsiCo (since 2007), and Red Bull GmbH (since 2008).